Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
3,341.11
3,534.43
3,224.64
2,873.97
3,558.87
3,275.16
2,701.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,341.11
3,534.43
3,224.64
2,873.97
3,558.87
3,275.16
2,701.23
Raw Material Cost
2,852.44
2,995.30
2,796.13
2,630.94
3,087.34
2,650.00
2,454.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
99.06
67.87
64.57
99.11
43.83
70.17
86.81
Selling and Distribution Expenses
93.13
101.38
87.09
125.30
85.60
82.76
86.90
Other Expenses
-9.91
-6.79
-6.46
-9.91
-4.38
-7.02
-8.68
Total Expenditure (Excl Depreciation)
2,945.57
3,096.68
2,883.22
2,756.24
3,172.95
2,732.76
2,541.66
Operating Profit (PBDIT) excl Other Income
395.5
437.8
341.4
117.69999999999999
385.90000000000003
542.4
159.60000000000002
Other Income
-2.26
24.29
63.45
144.58
22.77
114.26
93.86
Operating Profit (PBDIT)
449.90
483.61
445.95
308.09
452.04
674.58
284.62
Interest
99.06
67.87
64.57
99.11
43.83
70.17
86.81
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
488.67
539.13
428.51
243.03
471.53
625.17
246.47
Depreciation
56.62
21.57
41.09
45.78
43.34
17.91
31.19
Profit Before Tax
294.22
394.17
340.29
159.91
364.87
586.50
166.63
Tax
73.84
137.20
138.80
7.84
153.53
210.90
72.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
220.38
256.98
201.50
152.07
211.35
375.60
94.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
220.38
256.98
201.50
152.07
211.35
375.60
94.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
220.38
256.98
201.50
152.07
211.35
375.60
94.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
5,569.47
5,349.10
5,834.63
5,633.13
5,483.32
5,271.97
5,467.52
Earnings per share (EPS)
0.96
1.12
0.88
0.67
0.93
1.64
0.41
Diluted Earnings per share
0.96
1.12
0.88
0.67
0.93
1.64
0.41
Operating Profit Margin (Excl OI)
11.84%
12.39%
10.59%
4.1%
10.84%
16.56%
5.91%
Gross Profit Margin
10.5%
11.76%
11.83%
7.16%
11.47%
18.45%
7.32%
PAT Margin
6.6%
7.27%
6.25%
5.29%
5.94%
11.47%
3.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2025 is -5.47% vs 9.61% in Dec 2024
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2025 is -14.24% vs 27.54% in Dec 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2025 is -1.55% vs 20.08% in Dec 2024
Interest
QoQ Growth in quarter ended Mar 2025 is 45.95% vs 5.11% in Dec 2024
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024
Compare Quarterly Results Of Citi Pharma Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(PKR)
Change(%)
Net Sales
3,341.11
5,091.90
-1,750.79
-34.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,341.11
5,091.90
-1,750.79
-34.38%
Raw Material Cost
2,852.44
3,025.41
-172.97
-5.72%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
99.06
109.72
-10.66
-9.72%
Selling and Distribution Expenses
93.13
1,582.13
-1,489.00
-94.11%
Other Expenses
-9.91
-10.97
1.06
9.66%
Total Expenditure (Excl Depreciation)
2,945.57
4,607.54
-1,661.97
-36.07%
Operating Profit (PBDIT) excl Other Income
395.54
484.36
-88.82
-18.34%
Other Income
-2.26
26.14
-28.40
-108.65%
Operating Profit (PBDIT)
449.90
782.66
-332.76
-42.52%
Interest
99.06
109.72
-10.66
-9.72%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
488.67
2,066.49
-1,577.82
-76.35%
Depreciation
56.62
267.91
-211.29
-78.87%
Profit Before Tax
294.22
405.03
-110.81
-27.36%
Tax
73.84
157.22
-83.38
-53.03%
Provisions and contingencies
0
0
0.00
Profit After Tax
220.38
199.47
20.91
10.48%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
220.38
199.47
20.91
10.48%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
48.34
-48.34
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
220.38
247.81
-27.43
-11.07%
Equity Capital
0
0
0.00
Face Value
10.00
10.00
0.00
Reserves
5,569.47
12,169.53
-6,600.06
-54.23%
Earnings per share (EPS)
0.96
4.59
-3.63
-79.08%
Diluted Earnings per share
0.96
4.59
-3.63
-79.08%
Operating Profit Margin (Excl OI)
11.84%
9.60%
0.00
2.24%
Gross Profit Margin
10.50%
13.22%
0.00
-2.72%
PAT Margin
6.60%
3.92%
0.00
2.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 334.11 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is -5.47% vs 9.61% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -6.12% vs 32.37% in Mar 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 22.04 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is -14.24% vs 27.54% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 4.31% vs 127.69% in Mar 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 45.22 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is -1.55% vs 20.08% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 5.33% vs 35.81% in Mar 2024
Quarterly - Interest
Interest 9.91 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 45.95% vs 5.11% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 126.26% vs -71.92% in Mar 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.84%
in Mar 2025Figures in %
QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
